Register by March 13th and SAVE $300*!
(Mention Promo Code: JZT974)
RegisterRequest BrochureView Website
Conference Chairman: Tony Dutta, Senior Vice President of Operations, IDISElite Speakers Include: Zareen Ahmed, Corporate Regulatory Affairs-Regulatory CMC, sanofi-aventis David Bernstein, Ph.D., Consultant, Bernstein CMC Regulatory Consulting Christina Butta, Senior Principal Scientist, Pfizer Inc Tiffany Cavallaro, Clinical Supply Planning Manager, Merck Scott Eaton, Regulatory CMC, Pfizer Inc Jim Krupa, Associate Director, Planning and Coordination, Cephalon Micheline Marshall, Director, Clinical Pharmacy, Wyeth Gail Owens, Corporate Regulatory Affairs-RCMC, sanofi-aventis Frank Reale, Associate Director, Worldwide Regulatory Coordination and Clinical Supplies, Merck John Simmons, CMC Consultant; Former Director, Office of New Drug Quality Assessment, FDA Mark Ware, Director, Clinical Trial Services, IDIS Jill Wechsler, Washington Editor, Pharmaceutical Executive Yolanda Bell, Global NAMP Business Process Owner, Amgen Chris Wilson, Chief Operating Officer, Keats Healthcare Ltd
www.cbinet.com/comparator
The First and Only Source for Invaluable Information on:
Market Dynamics Driving an Increase in Comparator Studies and Keys to Success
Selection:Register by 3/13/09 Standard
2-Day Conference $1695$1995
Conference Co-Sponsor:
http://www.idispharma.com/
2009 Sponsors:
http://www.myoderm.com/, http://www.myoderm.com/, http://www.almacgroup.com/pharmaservices/, http://www.adiramedica.com/, http://www.pharmarama.com/about.htm, http://www.bilcare.com/, http://www.keatshealthcare.co.uk/, http://www.multipharma.ch/
Offer not valid on workshop only or academic registrations.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.